Deracemization enantioselective oxidation

J )-Mandelic acid 3 is a useful chiral synthon for the production of pharmaceuticals such as semi-synthetic penecillins, cephalosporins and antiobesity agents and many methods have been reported for the preparation of the optically pure material. A method to deracemize the racemate which is readily available on a large scale was developed by Ohta et al. using a combination of two biotransformations. The method consists of enantioselective oxidation of (S)-... 

Similarly to the case of amino acids, hydroxy acids can also be deracemized by combining an enantioselective oxidation with a non-enantioselective reduction with sodium borohydride. For example, the group of Soda has reported the transformation of DL-lactate into D-lactate in >99% (Scheme 5.38) [78]. 

Figure 14.34 Deracemization of racemic amines by repeated cycles of enzyme catalyzed enantioselective oxidation followed by nonselective chemical reduction.

The synthesis of optically pure L-phenylglycine via the deracemization of mandelic acid was reported via three steps (racemization, enantioselective oxidation and stereoselective reductive amination). Racemization by mandelate racemase combined with simultaneous oxidation and reduction reactions with cofactor recycling gave the amino acid in 97% ee and 94% yield (Scheme 4.43) [96]. 

Amine oxidases (AOs) can be used to synthesize primary, secondary and tertiary amines. Deracemization of chiral amines can be achieved by an enantioselective oxidation by an AO followed by a reduction using a nonselective reducing agent (Figure 7.12) [47d,76]. There are two types of AOs Type 1 (Cu/TOPA dependent, CAOs, EC.1.4.3.6) and Type 11 (Flavin dependent, EC 1.4.3.4). This chapter will solely focus on the flavin dependent monoamine oxidases. 

Deracemization by combining the enantioselective oxidation empioying a d-AAO with a non-seiective reducing agent (e.g.. 

Asymmetric synthesis of amines is a synthetically important research area due to the broad range of applications of chiral amines in fhe field of pharmaceuticals [134]. Amine oxidases are a versatile class of catalysts, which turned out to be very suitable for the preparation of chiral amines by means of desymmetrization or deracemization reactions. With respect to the latter, a racemic amine is enantioselectively oxidized by the amine oxidase, and simultaneously the in situ-formed imines or iminium ions, respectively, are reduced in a nonenantioselective chemical reduction process (with typically a borohydride) back to the racemic amine [135]. The key catalyst for such a... 

Assuming that the enzymatic reaction is highly enantioselective, then even after only four cycles the enantiomeric excess will have reached 93.4% whereas after seven catalytic cycles the enantiomeric excess is >99% (Figure 5.3). This type of deracemization is really a stereoinversion process in that the reactive enantiomer undergoes stereoinversion during the process. One of the challenges of developing this type of process is to find conditions under which the enzyme catalyst and chemical reactant can coexist, particularly in the case of redox chemistry in which the coexistence of an oxidant and reductant in the same reaction vessel is difficult to achieve. For this... 

The results actually showed a deracemization of the racemic hydroxyester 10 as opposed to enantioselective hydrolysis with formation of optically pure (R)-hydroxyester 10 and only 20 % loss in mass balance. Small quantities of ethyl 3-oxobutanoate 9 (<5%) were also detected throughout the reaction, leading the authors to suggest a multiple oxidation-reduction system with one dehydrogenase enzyme (DH-2) catalysing the irreversible reduction to the (R)-hydroxy-ester (Scheme 5). 

Chemoenzymatic processes involving oxidizing enzymes have been reported particularly for specific chemical syntheses. For example, industrially important amino acids can be deracemized by exploiting the enantioselectivity of amino acid oxidases a commercial process has recently been developed in which efficient... 

The group of Turner has reported the deracemization of amines [79]. The wild type of Type II monoamine oxidase from Aspergillus niger possesses very low but measurable activity toward the oxidation of L-a-methylbenzylamine. The oxidation of the D enantiomer is even slower. In vitro evolution led to the identification of a mutant with enhanced enantioselectivity, showing high E values (>100) for a variety of primary and secondary amines. An example is shown in Scheme 5.39. 

The alkylation products are synthetically useful because simple subsequent transformations furnishes precursors of important natural products as illustrated in Scheme 8E.23. Simple oxidative cleavage of allylic phthalimide 45 generates protected (5)-2-aminopimelic acid, whose dipeptide derivatives have shown antibiotic activity. The esterification via deracemization protocol is not limited to the use of bulky pivalic acid. The alkylation with sterically less hindered propionic acid also occurs with high enantioselectivity to give allylic ester 116, which has been utilized as an intermediate towards the antitumor agent phyllanthocin and the insect sex excitant periplanone. Dihydroxylation of the enantiopure allylic sulfone gives diol 117 with complete diastereoselectivity. Upon further transformation, the structurally versatile y-hydroxy-a,(f-un-saturated sulfone 118 is readily obtained enantiomerically pure. 

Matsumura and co-workers reported a memory effect of chirality in the electrochemical oxidation of 95 to give 96, although the enantioselectivity was modest (Scheme 3.25). The reaction is assumed to proceed via carbenium ion intermediate Q.46 The mechanism for asymmetric induction is not clear. A possible mechanism involves chiral acid (95)-mediated deracemization of racemic 96 produced by the electrochemical oxidation of 95. However, this suggestion may be eliminated based on the finding that treatment of racemic 96 with 95 in methanol containing 5% formic acid did not produce optically active 96. 

Deracemization by stereoinversion is a process in which one form (S of the racemic starting material (Rf -i- Sf) is enantioselectively transformed into an intermediate (Si) which can in turn react to give the form of opposite configuration (Rf). An example of this method could be the selective oxidation of one enantiomer of a racemic secondary alcohol and the subsequent reduction with a catalyst of opposite stereopreference [2]. 

Amino Acid Oxidase and Chemical In Situ Reduction of the Initially Formed Imino Compound A simple and interesting procedure for the deracemization of a-amino acids was introduced by Soda [48], who combined the oxidation of the D-enantiomer of D,L-proline to dehydro-prohne with a chemical reduction of the imine 21 in on -pot, thereby restoring the racemic mixture. If the reaction in the first step is completely enantioselective, the e.e. of the amino acid after one cycle is 50%. Repeating the reaction in successive cycles raises the e.e. close to 100% (Scheme 13.19). 

---